Drug marketing authorisation holders have until 1 August to submit applications to the UK Medicines and Healthcare products Regulatory Agency to make any labelling changes that might be required for their products to remain in accordance with the European medicines legislation, Directive 2001/83/EC, as amended1,2...
Please login to read the full article.
